PMC:7247521 / 0-895
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1 | 19-34 | Disease | denotes | COVID-19 injury | MESH:C000657245 |
| 3 | 221-229 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 5 | 356-365 | Species | denotes | 2019-nCov | Tax:2697049 |
| 7 | 428-436 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 33 | 863-877 | Gene | denotes | oxidoreductase | Gene:8630 |
| 35 | 811-814 | Chemical | denotes | FUs | |
| 36 | 888-893 | Chemical | denotes | lipid | MESH:D008055 |
| 39 | 544-552 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 19-27 | SP_7 | denotes | COVID-19 |
| T2 | 71-76 | NCBITaxon:10239 | denotes | viral |
| T3 | 109-118 | GO:0008152 | denotes | metabolic |
| T4 | 221-229 | SP_7 | denotes | COVID-19 |
| T5 | 239-244 | NCBITaxon:10239 | denotes | viral |
| T6 | 250-263 | CHEBI:67079;CHEBI:67079 | denotes | -inflammatory |
| T7 | 268-277 | GO:0008152 | denotes | metabolic |
| T8 | 356-365 | SP_7 | denotes | 2019-nCov |
| T9 | 428-436 | SP_7 | denotes | COVID-19 |
| T16 | 544-552 | SP_7 | denotes | COVID-19 |
| T17 | 583-592 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T18 | 888-893 | CHEBI:18059;CHEBI:18059;GO:0006629 | denotes | lipid |
| T77241 | 19-27 | SP_7 | denotes | COVID-19 |
| T25522 | 71-76 | NCBITaxon:10239 | denotes | viral |
| T26726 | 109-118 | GO:0008152 | denotes | metabolic |
| T22563 | 221-229 | SP_7 | denotes | COVID-19 |
| T45473 | 239-244 | NCBITaxon:10239 | denotes | viral |
| T92290 | 250-263 | CHEBI:67079;CHEBI:67079 | denotes | -inflammatory |
| T26450 | 268-277 | GO:0008152 | denotes | metabolic |
| T9512 | 356-365 | SP_7 | denotes | 2019-nCov |
| T7610 | 428-436 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 888-893 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 19-27 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 28-34 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
| T3 | 221-229 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 428-436 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T5 | 544-552 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 96-104 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T2 | 166-167 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T3 | 480-481 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T4 | 514-517 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T5 | 576-582 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
| T6 | 878-886 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 756-764 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T2 | 888-893 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-130 | Sentence | denotes | Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming |
| T2 | 132-150 | Sentence | denotes | Graphical abstract |
| T3 | 152-162 | Sentence | denotes | Highlights |
| T4 | 163-205 | Sentence | denotes | • A novel FUNP analysis on QFPD function. |
| T5 | 206-290 | Sentence | denotes | • QFPD act on COVID-19 via anti-viral, anti-inflammatory and metabolic programming. |
| T6 | 291-366 | Sentence | denotes | • 9 QFPD ingredients presented good molecular docking score for 2019-nCov. |
| T7 | 367-437 | Sentence | denotes | • SGMH, MXSG and Others are the top 3 efficient formula for COVID-19. |
| T8 | 439-447 | Sentence | denotes | Abstract |
| T9 | 448-562 | Sentence | denotes | Qingfei Paidu decoction (QFPD), a multi-component herbal formula, has been widely used to treat COVID-19 in China. |
| T10 | 563-636 | Sentence | denotes | However, its active compounds and mechanisms of action are still unknown. |
| T11 | 637-765 | Sentence | denotes | Firstly, we divided QFPD into five functional units (FUs) according to the compatibility theory of traditional Chinese medicine. |